Global Health Research Initiative (GHRI) operational research grants for the Canadian International Immunization Initiative (CIII2) : project title "development of novel vaccination strategies against helicobacter pylori in Latin America"; final technical report (May 30, 2004 - May 30, 2006)

Abstract

Preliminary research suggests that H. pylon Lipopolysaccharide (LPS) phenotype falls within the previously reported Lewis xly classification with 3 % of strains being non-typeable. Interestingly, Lewis b occurs in over 20 % of strains tested. This is significant since North American H. pylon isolates lack Lewis a and Lewis b antigens and so far, these antigens were only reported in Asian isolates. The report describes a multidisciplinary research program aimed at identification of the optimal common LPS structure/s that can be utilized in the design of protective LPS-based conjugate vaccine in Latin America and Caribbean countries.

Description

Keywords

IMMUNIZATION, VACCINATION, DISEASE CONTROL, STRATEGIC PLANNING, CAPACITY BUILDING, LATIN AMERICA, METHODOLOGY, STATISTICAL ANALYSIS, PARTICIPATORY RESEARCH, CHILE, SOUTH AMERICA, CUBA, CANADA, GLOBAL HEALTH, HELICOBACTER PYLORI

Citation

DOI